BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 24244318)

  • 1. Drug repositioning by kernel-based integration of molecular structure, molecular activity, and phenotype data.
    Wang Y; Chen S; Deng N; Wang Y
    PLoS One; 2013; 8(11):e78518. PubMed ID: 24244318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational probing protein-protein interactions targeting small molecules.
    Wang YC; Chen SL; Deng NY; Wang Y
    Bioinformatics; 2016 Jan; 32(2):226-34. PubMed ID: 26415726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kernel-based data fusion improves the drug-protein interaction prediction.
    Wang YC; Zhang CH; Deng NY; Wang Y
    Comput Biol Chem; 2011 Dec; 35(6):353-62. PubMed ID: 22099632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network predicting drug's anatomical therapeutic chemical code.
    Wang YC; Chen SL; Deng NY; Wang Y
    Bioinformatics; 2013 May; 29(10):1317-24. PubMed ID: 23564845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational Study of Drugs by Integrating Omics Data with Kernel Methods.
    Wang YC; Deng N; Chen S; Wang Y
    Mol Inform; 2013 Dec; 32(11-12):930-41. PubMed ID: 27481139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards drug repositioning: a unified computational framework for integrating multiple aspects of drug similarity and disease similarity.
    Zhang P; Wang F; Hu J
    AMIA Annu Symp Proc; 2014; 2014():1258-67. PubMed ID: 25954437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico drug repositioning based on integrated drug targets and canonical correlation analysis.
    Chen H; Zhang Z; Zhang J
    BMC Med Genomics; 2022 Mar; 15(1):48. PubMed ID: 35249529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DrugNet: network-based drug-disease prioritization by integrating heterogeneous data.
    Martínez V; Navarro C; Cano C; Fajardo W; Blanco A
    Artif Intell Med; 2015 Jan; 63(1):41-9. PubMed ID: 25704113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico drug repositioning based on the integration of chemical, genomic and pharmacological spaces.
    Chen H; Zhang Z; Zhang J
    BMC Bioinformatics; 2021 Feb; 22(1):52. PubMed ID: 33557749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of polypharmacological profiles of drugs by the integration of chemical, side effect, and therapeutic space.
    Cheng F; Li W; Wu Z; Wang X; Zhang C; Li J; Liu G; Tang Y
    J Chem Inf Model; 2013 Apr; 53(4):753-62. PubMed ID: 23527559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico drug repositioning using deep learning and comprehensive similarity measures.
    Yi HC; You ZH; Wang L; Su XR; Zhou X; Jiang TH
    BMC Bioinformatics; 2021 Jun; 22(Suppl 3):293. PubMed ID: 34074242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similarity-based prediction for Anatomical Therapeutic Chemical classification of drugs by integrating multiple data sources.
    Liu Z; Guo F; Gu J; Wang Y; Li Y; Wang D; Lu L; Li D; He F
    Bioinformatics; 2015 Jun; 31(11):1788-95. PubMed ID: 25638810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Link prediction in drug-target interactions network using similarity indices.
    Lu Y; Guo Y; Korhonen A
    BMC Bioinformatics; 2017 Jan; 18(1):39. PubMed ID: 28095781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational Drug Repositioning with Random Walk on a Heterogeneous Network.
    Luo H; Wang J; Li M; Luo J; Ni P; Zhao K; Wu FX; Pan Y
    IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(6):1890-1900. PubMed ID: 29994051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Drug-Target Network-Based Supervised Machine Learning Repurposing Method Allowing the Use of Multiple Heterogeneous Information Sources.
    Nascimento ACA; Prudêncio RBC; Costa IG
    Methods Mol Biol; 2019; 1903():281-289. PubMed ID: 30547449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational drug repositioning through heterogeneous network clustering.
    Wu C; Gudivada RC; Aronow BJ; Jegga AG
    BMC Syst Biol; 2013; 7 Suppl 5(Suppl 5):S6. PubMed ID: 24564976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational drug repositioning based on the relationships between substructure-indication.
    Yang J; Zhang D; Liu L; Li G; Cai Y; Zhang Y; Jin H; Chen X
    Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33313675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug repositioning of herbal compounds via a machine-learning approach.
    Kim E; Choi AS; Nam H
    BMC Bioinformatics; 2019 May; 20(Suppl 10):247. PubMed ID: 31138103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting drug-target interaction network using deep learning model.
    You J; McLeod RD; Hu P
    Comput Biol Chem; 2019 Jun; 80():90-101. PubMed ID: 30939415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-aspect candidates for repositioning: data fusion methods using heterogeneous information sources.
    Arany Á; Bolgár B; Balogh B; Antal P; Mátyus P
    Curr Med Chem; 2013; 20(1):95-107. PubMed ID: 23210850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.